BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26712869)

  • 1. Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening.
    Gustinucci D; Giorgi Rossi P; Cesarini E; Broccolini M; Bulletti S; Carlani A; D'angelo V; D'amico MR; Di Dato E; Galeazzi P; Malaspina M; Martinelli N; Spita N; Tintori B; Giaimo MD; Passamonti B
    Am J Clin Pathol; 2016 Jan; 145(1):35-45. PubMed ID: 26712869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.
    Allia E; Ronco G; Coccia A; Luparia P; Macrì L; Fiorito C; Maletta F; Deambrogio C; Tunesi S; De Marco L; Gillio-Tos A; Sapino A; Ghiringhello B
    Cancer Cytopathol; 2015 Apr; 123(4):212-8. PubMed ID: 25534957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
    Giorgi Rossi P; Carozzi F; Ronco G; Allia E; Bisanzi S; Gillio-Tos A; De Marco L; Rizzolo R; Gustinucci D; Del Mistro A; Frayle H; Confortini M; Iossa A; Cesarini E; Bulletti S; Passamonti B; Gori S; Toniolo L; Barca A; Bonvicini L; Mancuso P; Venturelli F; Benevolo M;
    J Natl Cancer Inst; 2021 Mar; 113(3):292-300. PubMed ID: 32745170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
    Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
    BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test.
    Benevolo M; Vocaturo A; Caraceni D; French D; Rosini S; Zappacosta R; Terrenato I; Ciccocioppo L; Frega A; Giorgi Rossi P
    J Clin Microbiol; 2011 Jul; 49(7):2643-50. PubMed ID: 21525231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
    Reuschenbach M; Clad A; von Knebel Doeberitz C; Wentzensen N; Rahmsdorf J; Schaffrath F; Griesser H; Freudenberg N; von Knebel Doeberitz M
    Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.
    Wentzensen N; Fetterman B; Castle PE; Schiffman M; Wood SN; Stiemerling E; Tokugawa D; Bodelon C; Poitras N; Lorey T; Kinney W
    J Natl Cancer Inst; 2015 Dec; 107(12):djv257. PubMed ID: 26376685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].
    Zhan X; Wang S; Wu X; Qiu X; Li F; Zeng Y; Chen Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct; 34(10):937-941. PubMed ID: 30554588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
    Zhang R; Ge X; You K; Guo Y; Guo H; Wang Y; Geng L
    J Obstet Gynaecol Res; 2018 Nov; 44(11):2077-2084. PubMed ID: 30094887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study.
    Ren C; Zhu Y; Yang L; Zhang X; Liu L; Wang Z; Jiang D
    Virol J; 2019 Nov; 16(1):143. PubMed ID: 31752941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
    Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
    J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopy.
    Ordi J; Sagasta A; Munmany M; Rodríguez-Carunchio L; Torné A; del Pino M
    Cancer Cytopathol; 2014 Mar; 122(3):227-35. PubMed ID: 24757722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.
    Halfon P; Benmoura D; Agostini A; Khiri H; Martineau A; Penaranda G; Blanc B
    J Clin Virol; 2010 Feb; 47(2):177-81. PubMed ID: 20022804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
    Guo Z; Zhao DM; Zhang SK; Wu ZN; Sun XB; Jia MM; Chen Q; Guo LW; Chen PP; Zhang JG
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1094-1099. PubMed ID: 34695901
    [No Abstract]   [Full Text] [Related]  

  • 15. p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy.
    Donà MG; Vocaturo A; Giuliani M; Ronchetti L; Rollo F; Pescarmona E; Carosi M; Vocaturo G; Benevolo M
    Gynecol Oncol; 2012 Aug; 126(2):198-202. PubMed ID: 22588180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
    Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types.
    Giorgi Rossi P; Bisanzi S; Allia E; Mongia A; Carozzi F; Gillio-Tos A; De Marco L; Ronco G; Gustinucci D; Del Mistro A; Frayle H; Iossa A; Fantacci G; Pompeo G; Cesarini E; Bulletti S; Passamonti B; Rizzi M; Penon MG; Barca A; Benevolo M
    J Clin Microbiol; 2017 Apr; 55(4):1056-1065. PubMed ID: 28100595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
    Guan Y; Peng J; Yuan C; Mi X; Chen Z; Chen J; Chen A; Liu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):63-68. PubMed ID: 32314725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual staining for p16/Ki67 is a more specific test than cytology for triage of HPV-positive women.
    Areán-Cuns C; Mercado-Gutiérrez M; Paniello-Alastruey I; Mallor-Giménez F; Córdoba-Iturriagagoitia A; Lozano-Escario M; Santamaria-Martínez M
    Virchows Arch; 2018 Nov; 473(5):599-606. PubMed ID: 30094492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.